Lynne Sullivan's Insider Trades & SAST Disclosures
Lynne Sullivan's most recent trade in Unity Biotechnology Inc was a trade of 21,867 Common Stock, $0.0001 par value done at an average price of $1.0 . Disclosure was reported to the exchange on April 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lynne Sullivan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 02 Apr 2025 | 21,867 | 98,905 (0%) | 0% | 1.0 | 22,523 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 106,000 | 106,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 65,000 | 120,772 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Sale of securities on an exchange or to another person at price $ 2.23 per share. | 04 Feb 2025 | 153 | 55,772 (0%) | 0% | 2.2 | 341 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 04 Nov 2024 | 136 | 55,925 (0%) | 0% | 1.3 | 175 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 02 Aug 2024 | 139 | 56,061 (0%) | 0% | 1.5 | 213 | Common Stock, $0.0001 par value |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 25 Jun 2024 | 324 | 32,685 (0%) | 0% | 1.4 | 454 | Common Stock, $0.0001 par value |
| Inozyme Pharma Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Inozyme Pharma Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Other type of transaction at price $ 6.89 per share. | 18 Nov 2022 | 925 | 33,009 (0%) | 0% | 6.9 | 6,373 | Common Stock, $0.0001 par value |
| Inozyme Pharma Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 9,367 | 9,367 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 50,000 | 326,785 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 123,333 | 123,333 | - | - | Stock Option (Right to Buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | CFO & Head of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 30,833 | 270,833 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Inozyme Pharma Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 9,367 | 9,367 | - | - | Stock Option (right to buy) | |
| Unity Biotechnology Inc | Lynne Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2020 | 240,000 | 240,000 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Unity Biotechnology Inc | Lynne Sullivan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2020 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Inozyme Pharma Inc | Lynne Sullivan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 9,367 | 9,367 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges